From April 16 to 19, Urals Healthcare 2019, the specialized International Exhibition and Forum, was held at the Yekaterinburg Expo Centre, where a stand of Medsintez was presented too. The forum exhibition of medical equipment, tools, supplies, pharmaceuticals as well as medical and spa services was held for the first time ever.
On December 21, 2018, Epidemiology And Treatment Of Allergic Diseases, a scientific and practical conference of the Sverdlovsk region's allergologists and immunologists, was held, where Triazavirin, the domestic antiviral drug, was recommended as a treatment for viral infections that exacerbate bronchial asthma.
Today, the company has a developed technology for obtaining the RosinsulinAspart and RosinsulinGlargin substances as well as their dosage forms.
On November 15, 2018, within the framework of a regular meeting of the Sverdlovsk Association of Endocrinologists, the results of clinical trials of Rosinsulin M Mix 30/70, 2-phase genetically engineered human insulin, were presented in Rymar Oksana's report “Basic clinical and laboratory parameters in patients with type 2 diabetes mellitus amid the therapy of combined domestic insulins and metformins in the real-world clinical practice."
+7 (34370) 2-50-61
+7 (34370) 2-54-95
Torgovaya 15, Novouralsk, Sverdlovsk region, Russia, 624130